Cargando…

Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing–Remitting Multiple Sclerosis Treated With Dimethylfumarate

Background: The changes of the gut-brain axis have been recently recognized as important components in multiple sclerosis (MS) pathogenesis. Objectives: To evaluate the effects of DMF on intestinal barrier permeability and mucosal immune responses. Methods: We investigated intestinal permeability (I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buscarinu, Maria C., Gargano, Francesca, Lionetto, Luana, Capi, Matilde, Morena, Emanuele, Fornasiero, Arianna, Reniè, Roberta, Landi, Anna C., Pellicciari, Giulia, Romano, Carmela, Mechelli, Rosella, Romano, Silvia, Borsellino, Giovanna, Battistini, Luca, Simmaco, Maurizio, Fagnani, Corrado, Salvetti, Marco, Ristori, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426620/ https://www.ncbi.nlm.nih.gov/pubmed/34512507 http://dx.doi.org/10.3389/fneur.2021.683398

Ejemplares similares

The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology
por: Buscarinu, Maria Chiara, et al.
Publicado: (2019)

MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune Diseases
por: Mechelli, Rosella, et al.
Publicado: (2021)

Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?
por: Bellucci, Gianmarco, et al.
Publicado: (2021)

A Case of Double Standard: Sex Differences in Multiple Sclerosis Risk Factors
por: Angeloni, Benedetta, et al.
Publicado: (2021)

Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome
por: Umeton, Renato, et al.
Publicado: (2022)

Genome-Wide Multiple Sclerosis Association Data and Coagulation
por: La Starza, Sara, et al.
Publicado: (2019)

Autoimmune Encephalitis and CSF Anti-GluR3 Antibodies in an MS Patient after Alemtuzumab Treatment
por: Buscarinu, Maria Chiara, et al.
Publicado: (2019)

Late-Onset MS: Disease Course and Safety-Efficacy of DMTS
por: Buscarinu, Maria Chiara, et al.
Publicado: (2022)

EBV-specific CD8 T lymphocytes and B cells during glatiramer acetate therapy in patients with MS
por: Guerrera, Gisella, et al.
Publicado: (2020)

A “Candidate-Interactome” Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis
por: Mechelli, Rosella, et al.
Publicado: (2013)

Circulating hsa-miR-323b-3p in Huntington's Disease: A Pilot Study
por: Ferraldeschi, Michela, et al.
Publicado: (2021)

Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority
por: Romano, Silvia, et al.
Publicado: (2019)

Proinflammatory mucosal-associated invariant CD8+ T cells react to gut flora yeasts and infiltrate multiple sclerosis brain
por: Gargano, Francesca, et al.
Publicado: (2022)

SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets
por: Bellucci, Gianmarco, et al.
Publicado: (2020)

Reworking GWAS Data to Understand the Role of Nongenetic Factors in MS Etiopathogenesis
por: Mechelli, Rosella, et al.
Publicado: (2020)

Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis
por: Angelini, Daniela F., et al.
Publicado: (2013)

Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease
por: Morena, Emanuele, et al.
Publicado: (2023)

A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials
por: Eleuteri, C., et al.
Publicado: (2017)

Percentages of CD4+CD161+ and CD4−CD8−CD161+ T Cells in the Synovial Fluid Are Correlated with Disease Activity in Rheumatoid Arthritis
por: Miao, Jinlin, et al.
Publicado: (2015)

CD161-Expressing Human T Cells
por: Fergusson, Joannah R., et al.
Publicado: (2011)

CD161+ regulatory t cells in immune regulation
por: Duurland, Chantal, et al.
Publicado: (2014)

Anti-Inflammatory Dimethylfumarate: A Potential New Therapy for Asthma?
por: Seidel, Petra, et al.
Publicado: (2013)

Geographic Population Structure in Epstein-Barr Virus Revealed by Comparative Genomics
por: Chiara, Matteo, et al.
Publicado: (2016)

CD161(+) Tconv and CD161(+) Treg Share a Transcriptional and Functional Phenotype despite Limited Overlap in TCRβ Repertoire
por: Duurland, Chantal L., et al.
Publicado: (2017)

Identification of Cytolytic CD161(−)CD56(+) Regulatory CD8 T Cells in Human Peripheral Blood
por: Hu, Dan, et al.
Publicado: (2013)

Depletion of Saccharomyces cerevisiae in psoriasis patients, restored by Dimethylfumarate therapy (DMF)
por: Eppinga, Hester, et al.
Publicado: (2017)

CD8(+)CD161(+) T-Cells: Cytotoxic Memory Cells With High Therapeutic Potential
por: Konduri, Vanaja, et al.
Publicado: (2021)

CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review
por: Rinaldi, Virginia, et al.
Publicado: (2022)

LLT1-CD161 Interaction in Cancer: Promises and Challenges
por: Braud, Veronique M., et al.
Publicado: (2022)

Switching from a fumaric acid ester mixture to dimethylfumarate monotherapy in psoriasis
por: Warren, R.B., et al.
Publicado: (2019)

Increased CD8(+) T cell responses to apoptotic T cell-associated antigens in multiple sclerosis
por: Lolli, Francesco, et al.
Publicado: (2013)

Loss of Circulating CD8+ CD161(high) T Cells in Primary Progressive Multiple Sclerosis
por: Acquaviva, Massimo, et al.
Publicado: (2019)

Frequency of CD4+CD161+ T Cell and Interleukin-10 Expression in Inflammatory Bowel Diseases
por: Tsuchiya, Kazuyo, et al.
Publicado: (2017)

The identification and functional analysis of CD8+PD-1+CD161+ T cells in hepatocellular carcinoma
por: Li, Zhixuan, et al.
Publicado: (2020)

Cytotoxic CD161(−)CD8(+) T(EMRA) cells contribute to the pathogenesis of systemic lupus erythematosus
por: Xiong, Hui, et al.
Publicado: (2023)

One, No One, and One Hundred Thousand: T Regulatory Cells' Multiple Identities in Neuroimmunity
por: Sambucci, Manolo, et al.
Publicado: (2019)

Differential Effect of Cytomegalovirus Infection with Age on the Expression of CD57, CD300a, and CD161 on T-Cell Subpopulations
por: Hassouneh, Fakhri, et al.
Publicado: (2017)

Association Between Impaired Vα7.2+CD161++CD8+ (MAIT) and Vα7.2+CD161-CD8+ T-Cell Populations and Gut Dysbiosis in Chronically HIV- and/or HCV-Infected Patients
por: Merlini, Esther, et al.
Publicado: (2019)

Expansion of mixed immune cells using CD3/CD161 co-stimulation for the treatment of cancer
por: Tsumura, Ryo, et al.
Publicado: (2023)

Impact of Aging on the Frequency, Phenotype, and Function of CD161-Expressing T Cells
por: van der Geest, Kornelis S. M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pcpgg61j9t366pcjkusgoq7vbk